Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacterium breve in Children With Celiac Disease
NCT02244047Phase 2Completed
- Sponsor
- University Clinical Centre Maribor
- Start
- Oct 2013
- Primary completion
- Jun 2014
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 2 trial of Bifidobacterium breve in celiac disease, sponsored by University Clinical Centre Maribor. Started Oct 2013; status: completed.
02
Drugs
Bifidobacterium breve
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT02244047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244047.